Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-044426

Chief Business Officer acquired 10,417 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
D'Silva Andrew J. Chief Business Officer 2025-08-21 Grant or award +10,417 47,514 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
D'Silva Andrew J. Chief Business Officer 2025-08-21 Grant or award · Stock Option +23,437 23,437 D: show line 2 in the form
Loading xslF345X05/wk-form4_1759850764.xml…